FSD Pharma shares are trading higher after Celly Nutrition, which is backed by FSD Pharma, announced the upcoming launch of its 'unbuzzd' recovery drink.
Portfolio Pulse from Benzinga Newsdesk
FSD Pharma shares are trading higher following the announcement by Celly Nutrition, a company backed by FSD Pharma, about the upcoming launch of its 'unbuzzd' recovery drink.
August 09, 2024 | 5:25 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
FSD Pharma shares are experiencing an uptick due to the announcement by Celly Nutrition, which is supported by FSD Pharma, about the launch of its 'unbuzzd' recovery drink.
The launch of a new product by Celly Nutrition, which is backed by FSD Pharma, is likely to positively impact FSD Pharma's stock price in the short term as it indicates potential revenue growth and market expansion.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100